89bio, Inc. (ETNB)

89bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	217.57	316.16	55.26	52.46	98.21	93.36
Short-Term Investments	344.72	262.71	132.91	98.29	106.45	0
Cash & Cash Equivalents	562.29	578.87	188.16	150.75	204.65	93.36
Cash Growth	16.93%	207.65%	24.82%	-26.34%	119.21%	729.35%
Other Current Assets	12.49	14.66	7.92	11.24	5.55	1.97
Total Current Assets	574.78	593.53	196.08	161.98	210.2	95.33
Property, Plant & Equipment	2.16	2.34	0.46	0.15	0.17	0.16
Other Long-Term Assets	0.39	0.4	0.29	0.29	0.71	0.07
Total Long-Term Assets	2.54	2.74	0.74	0.44	0.87	0.23
Total Assets	577.32	596.27	196.82	162.42	211.07	95.55
Accounts Payable	15.35	8.59	12.5	6.84	2.07	0.99
Current Debt	2.59	0.5	0.17	2.5	0	0
Other Current Liabilities	20.3	20.53	11.94	10.19	6.05	4.62
Total Current Liabilities	38.24	29.61	24.61	19.54	8.11	5.61
Long-Term Debt	24.71	26.61	20.38	16.9	0	0
Other Long-Term Liabilities	3.84	3.74	0	0.03	0	0
Total Long-Term Liabilities	28.54	30.35	20.38	16.93	0	0
Total Liabilities	66.78	59.96	44.99	36.47	8.11	5.61
Total Debt	27.3	27.11	20.55	19.4	0	0
Debt Growth	10.77%	31.94%	5.92%	-	-	-
Retained Earnings	-509.11	-457.43	-315.24	-213.22	-123.1	-73.6
Comprehensive Income	-0.52	0.19	-0.35	-0.06	-0.01	0
Shareholders' Equity	510.54	536.31	151.83	125.96	202.96	89.94
Net Cash / Debt	534.99	551.76	167.61	131.35	204.65	93.36
Net Cash / Debt Growth	17.26%	229.19%	27.61%	-35.82%	119.21%	729.35%
Net Cash Per Share	5.58	7.75	4.82	6.54	12.72	39.83
Working Capital	536.54	563.92	171.47	142.45	202.09	89.72
Book Value Per Share	5.33	7.54	4.36	6.27	12.62	38.37

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).